data_2mg2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mg2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt . . . . . 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.2 t80 . . . . . 0 N--CA 1.471 0.575 0 CA-C-O 119.885 -0.102 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -117.92 9.82 12.97 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.349 1.86 . . . . 0.0 113.791 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -86.21 161.2 18.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.191 2.196 . . . . 0.0 112.078 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -143.67 167.23 22.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.345 1.858 . . . . 0.0 110.87 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -53.53 -31.07 44.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.897 1.279 . . . . 0.0 113.265 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.75 -22.99 66.97 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.197 1.399 . . . . 0.0 113.328 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.57 -23.87 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.095 1.358 . . . . 0.0 112.389 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -61.57 -28.22 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.774 -1.203 . . . . 0.0 112.114 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 t -58.12 -31.44 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.013 -1.054 . . . . 0.0 113.593 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.99 -43.41 92.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.322 1.049 . . . . 0.0 111.641 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -62.44 -43.54 98.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.735 0.814 . . . . 0.0 111.54 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -45.1 72.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.869 0.868 . . . . 0.0 111.585 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -34.93 70.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.359 1.064 . . . . 0.0 113.513 175.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -58.54 -45.15 89.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.02 . . . . 0.0 112.026 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.33 -37.16 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.712 -0.618 . . . . 0.0 110.594 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.8 -41.17 77.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.248 1.019 . . . . 0.0 112.144 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -58.33 -42.76 87.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.777 1.231 . . . . 0.0 112.527 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.38 -39.7 70.44 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.872 0.76 . . . . 0.0 112.279 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.2 -28.78 23.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.514 1.926 . . . . 0.0 114.464 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.1 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -117.6 17.1 14.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.716 2.006 . . . . 0.0 114.308 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -87.33 127.43 35.19 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.766 1.627 . . . . 0.0 111.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -69.59 138.35 53.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.785 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -57.32 -29.72 64.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.969 0.908 . . . . 0.0 113.254 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.79 -27.44 69.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.89 -32.27 34.9 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 0.0 111.798 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -57.6 -48.0 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.501 1.12 . . . . 0.0 111.507 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -63.38 -28.99 70.37 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.575 -0.703 . . . . 0.0 112.55 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -68.28 -34.3 75.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.263 0.938 . . . . 0.0 110.838 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -72.12 -35.65 69.21 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.096 -1.003 . . . . 0.0 112.828 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -49.87 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.168 0.987 . . . . 0.0 113.195 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -77.2 -31.87 55.59 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -63.44 -36.44 83.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.584 1.153 . . . . 0.0 112.991 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.1 mt -59.89 -53.78 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.114 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -65.41 -31.72 72.96 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.24 1.016 . . . . 0.0 113.522 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.2 -44.91 88.32 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.448 1.099 . . . . 0.0 110.344 174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -55.29 -46.66 76.21 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.065 -0.397 . . . . 0.0 111.411 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -85.03 -29.64 24.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.792 1.637 . . . . 0.0 112.898 -177.692 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.39 0.138 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -129.0 122.42 30.04 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.565 1.946 . . . . 0.0 110.212 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -125.37 172.53 9.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.665 2.386 . . . . 0.0 110.666 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.49 162.53 15.12 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.842 0.857 . . . . 0.0 112.149 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -58.14 -29.13 65.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.002 -1.061 . . . . 0.0 113.254 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -61.22 -29.04 69.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.304 1.442 . . . . 0.0 113.204 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.24 -25.77 36.37 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 0.0 111.194 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -73.57 -41.57 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.203 1.001 . . . . 0.0 110.85 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -60.95 -28.09 68.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.258 -0.901 . . . . 0.0 112.947 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.6 -43.27 90.17 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.566 0.746 . . . . 0.0 110.887 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.72 -34.05 76.98 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.248 -0.907 . . . . 0.0 113.148 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 -49.8 65.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 112.835 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -76.05 -28.63 57.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -65.95 -42.3 90.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.763 0.825 . . . . 0.0 112.314 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -57.61 -34.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 0.0 110.888 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.31 -26.17 66.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.543 1.537 . . . . 0.0 113.443 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.99 -39.71 93.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.883 0.873 . . . . 0.0 111.105 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.88 -43.94 86.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.748 -0.595 . . . . 0.0 110.719 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -19.81 27.5 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.637 1.575 . . . . 0.0 112.401 177.198 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.507 0.194 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -154.26 73.1 0.91 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.705 1.202 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -124.32 -69.87 0.78 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 111.381 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.58 142.96 21.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.378 1.471 . . . . 0.0 110.287 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -61.04 -33.82 73.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.381 0.672 . . . . 0.0 112.291 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -73.43 -28.66 62.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.124 0.97 . . . . 0.0 112.945 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.38 -19.56 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.751 -1.218 . . . . 0.0 112.746 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.82 -25.47 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.705 1.202 . . . . 0.0 112.429 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -62.36 -29.65 70.62 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.592 -1.317 . . . . 0.0 112.24 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.58 -35.45 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.762 1.225 . . . . 0.0 112.454 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -63.7 -38.73 92.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.626 0.77 . . . . 0.0 111.699 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.27 -36.27 65.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.198 0.999 . . . . 0.0 111.647 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -54.83 -48.19 73.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.703 0.801 . . . . 0.0 112.156 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -65.27 -43.81 90.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.496 0.718 . . . . 0.0 112.061 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 mt -56.34 -55.22 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.98 0.912 . . . . 0.0 110.599 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.53 87.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.662 1.185 . . . . 0.0 112.447 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.96 -43.85 91.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.984 1.313 . . . . 0.0 111.083 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -56.08 -45.0 79.5 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.682 -0.636 . . . . 0.0 111.236 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.12 -25.11 27.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.95 93.68 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.223 1.409 . . . . 0.0 112.097 -173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -125.92 -76.23 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.045 2.538 . . . . 0.0 110.763 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -135.02 157.6 46.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.349 1.859 . . . . 0.0 110.858 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -57.37 -27.86 62.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.314 1.046 . . . . 0.0 113.134 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -23.0 63.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 113.465 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.24 -38.74 10.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.782 0.833 . . . . 0.0 111.012 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.96 -42.9 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.314 1.046 . . . . 0.0 111.51 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -60.03 -31.88 70.37 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.931 0.787 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -69.91 -48.52 58.24 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.571 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -61.39 -38.53 87.38 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.09 -36.47 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.983 0.913 . . . . 0.0 112.208 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -36.97 80.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.39 1.476 . . . . 0.0 113.656 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -61.02 -45.77 93.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 111.659 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.8 -43.86 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.808 -0.557 . . . . 0.0 109.696 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -55.61 -37.88 68.72 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.236 1.014 . . . . 0.0 113.088 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -58.84 -44.23 90.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.73 0.812 . . . . 0.0 111.298 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.83 -46.8 88.11 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.727 -0.608 . . . . 0.0 110.762 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -12.42 59.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.848 2.459 . . . . 0.0 113.457 -171.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.908 -0.567 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -88.02 -16.27 34.12 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.51 173.99 3.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.842 1.257 . . . . 0.0 112.265 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.74 132.76 54.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.71 0.804 . . . . 0.0 111.624 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -55.35 -29.79 59.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.526 1.13 . . . . 0.0 113.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -31.51 67.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.095 1.758 . . . . 0.0 113.315 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.2 -33.27 33.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.07 -1.019 . . . . 0.0 111.177 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.38 -39.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.918 1.287 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -61.94 -32.33 72.74 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.086 -1.009 . . . . 0.0 112.597 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -61.76 -39.33 91.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.821 0.737 . . . . 0.0 111.884 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -64.24 -45.67 87.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.801 0.728 . . . . 0.0 111.616 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -41.77 92.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.966 0.906 . . . . 0.0 112.58 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -34.39 77.51 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.694 -0.629 . . . . 0.0 112.535 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.5 -25.75 67.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.861 0.865 . . . . 0.0 113.036 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.66 -48.04 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.881 1.272 . . . . 0.0 110.731 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -70.56 -32.3 69.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.377 1.071 . . . . 0.0 112.693 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.85 -39.51 89.4 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.727 0.811 . . . . 0.0 110.995 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.17 -45.97 75.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.359 0.981 . . . . 0.0 111.69 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -85.47 -27.44 25.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.995 1.718 . . . . 0.0 113.132 -175.505 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.141 0.496 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.51 114.05 26.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.639 1.575 . . . . 0.0 110.689 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -127.33 -66.08 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.59 1.556 . . . . 0.0 112.455 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -148.77 176.76 10.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.036 1.735 . . . . 0.0 111.17 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -52.02 -29.74 22.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 113.359 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.84 -35.32 66.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.514 1.526 . . . . 0.0 112.744 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -33.11 55.1 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.246 -0.909 . . . . 0.0 111.749 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.6 -33.22 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.924 0.89 . . . . 0.0 112.108 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -62.31 -29.3 70.34 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.78 -1.2 . . . . 0.0 113.455 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.93 -43.2 88.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.914 0.885 . . . . 0.0 111.182 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.97 -42.11 97.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.537 0.735 . . . . 0.0 112.129 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -54.98 -39.02 68.54 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.21 0.604 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -43.78 86.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.237 1.015 . . . . 0.0 113.073 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -58.12 -43.54 87.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.182 0.993 . . . . 0.0 112.229 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -68.97 -41.64 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.665 0.786 . . . . 0.0 110.801 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -36.15 65.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.985 1.314 . . . . 0.0 113.2 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.14 -43.67 98.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.51 0.724 . . . . 0.0 111.158 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.26 -45.5 93.07 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.428 -0.795 . . . . 0.0 110.83 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -26.02 22.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.839 2.056 . . . . 0.0 112.585 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -56.81 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.773 1.629 . . . . 0.0 112.642 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.93 153.81 50.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.827 2.051 . . . . 0.0 110.876 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.52 139.63 55.64 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.192 0.997 . . . . 0.0 110.192 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -55.64 -30.5 61.08 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 112.92 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -38.2 84.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.768 1.227 . . . . 0.0 112.16 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -32.4 65.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.669 1.188 . . . . 0.0 112.482 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.58 -27.42 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 0.0 111.926 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -58.78 -35.27 72.52 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.016 -1.053 . . . . 0.0 113.167 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -44.07 88.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 111.801 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -64.39 -41.87 96.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.25 1.02 . . . . 0.0 112.178 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.22 -40.48 94.15 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.778 0.831 . . . . 0.0 112.111 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -28.17 69.89 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.11 -28.63 63.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.186 -0.946 . . . . 0.0 113.192 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.38 -41.51 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.418 1.087 . . . . 0.0 110.395 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -36.44 79.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 112.116 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.75 -39.78 81.95 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.994 0.918 . . . . 0.0 112.733 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -54.16 -45.26 72.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.387 0.994 . . . . 0.0 111.903 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 -21.13 29.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.469 1.508 . . . . 0.0 112.125 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 91.13 7.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.797 1.181 . . . . 0.0 111.633 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -122.76 168.77 11.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.106 1.362 . . . . 0.0 112.375 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -68.21 162.02 25.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.412 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -56.37 -29.21 61.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.886 0.874 . . . . 0.0 113.261 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -62.6 -28.03 69.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.816 1.647 . . . . 0.0 113.087 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -84.68 -39.92 18.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.757 1.223 . . . . 0.0 111.096 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.28 -48.4 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.198 0.999 . . . . 0.0 110.799 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -58.89 -31.85 68.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -60.52 -44.57 95.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.58 1.082 . . . . 0.0 112.059 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.14 -42.29 66.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.618 0.767 . . . . 0.0 111.575 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.65 -29.37 70.02 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.593 0.757 . . . . 0.0 112.423 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -33.18 68.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.404 1.081 . . . . 0.0 113.389 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -67.32 -25.89 66.24 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.329 -0.857 . . . . 0.0 113.218 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mm -59.89 -40.87 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.094 -1.004 . . . . 0.0 110.516 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -70.98 -32.06 68.8 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.335 1.054 . . . . 0.0 112.84 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.17 -44.54 92.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.953 0.797 . . . . 0.0 111.236 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.25 -43.99 75.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.93 0.492 . . . . 0.0 111.875 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -18.87 30.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.987 2.115 . . . . 0.0 111.799 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.4 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.82 124.96 23.35 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.024 0.929 . . . . 0.0 111.291 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.16 170.2 14.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.641 1.177 . . . . 0.0 112.16 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.01 152.25 35.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.91 1.684 . . . . 0.0 111.959 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -53.49 -26.64 21.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.629 1.571 . . . . 0.0 114.128 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -24.15 59.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.929 1.691 . . . . 0.0 113.468 175.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -82.59 -42.71 17.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.772 1.229 . . . . 0.0 111.448 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.1 mm -62.41 -46.33 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.916 1.286 . . . . 0.0 110.855 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -61.49 -29.49 70.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -44.6 94.54 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.188 0.995 . . . . 0.0 111.664 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -70.95 -42.75 69.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.141 0.976 . . . . 0.0 111.93 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.77 -29.07 69.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -32.7 71.01 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.217 -0.927 . . . . 0.0 112.853 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.76 -27.01 67.26 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.45 -38.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.009 -1.057 . . . . 0.0 111.034 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.25 -28.86 61.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.609 -0.682 . . . . 0.0 112.665 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.99 -39.68 95.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.99 0.916 . . . . 0.0 111.654 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.1 -45.4 71.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.496 0.718 . . . . 0.0 111.609 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -13.74 35.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.814 2.045 . . . . 0.0 112.932 178.528 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -74.35 53.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.097 1.759 . . . . 0.0 113.09 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -71.19 168.24 17.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.944 1.698 . . . . 0.0 111.411 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.64 161.7 14.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 112.628 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -58.34 -33.65 69.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 112.849 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -36.49 83.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.108 0.963 . . . . 0.0 112.083 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -21.31 63.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.337 1.055 . . . . 0.0 112.848 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.27 -20.69 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.114 0.966 . . . . 0.0 110.942 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -57.78 -32.49 67.56 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.141 -0.974 . . . . 0.0 111.608 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -36.95 78.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.971 0.908 . . . . 0.0 112.148 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.1 -35.0 64.14 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.548 -0.72 . . . . 0.0 112.412 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -49.72 54.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.587 1.555 . . . . 0.0 112.619 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -77.63 -28.18 51.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.26 -39.31 93.68 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.106 -0.996 . . . . 0.0 112.342 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.7 mt -60.17 -30.38 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.121 0.968 . . . . 0.0 111.525 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.08 -36.16 78.92 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.792 -1.193 . . . . 0.0 111.665 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.9 mt -58.14 -40.81 82.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.117 0.967 . . . . 0.0 111.783 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -56.3 -44.8 80.21 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.714 0.806 . . . . 0.0 111.608 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -81.1 -8.47 59.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.412 2.685 . . . . 0.0 113.141 -176.61 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -65.38 141.74 58.45 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.079 -1.638 . . . . 0.0 111.667 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.06 -71.46 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.041 . . . . 0.0 111.008 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -155.41 139.1 16.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.492 1.517 . . . . 0.0 110.213 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -55.85 -31.44 62.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.357 1.063 . . . . 0.0 113.26 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.97 63.87 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.34 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -85.22 -23.59 28.2 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.213 -0.929 . . . . 0.0 112.665 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.77 -24.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.235 1.414 . . . . 0.0 112.171 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -55.45 -32.42 62.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.072 -1.017 . . . . 0.0 113.494 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -60.76 -42.5 97.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.247 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -66.82 -43.41 83.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 111.472 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -58.94 -43.56 91.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.782 0.833 . . . . 0.0 111.696 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -33.47 73.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 112.951 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.56 -45.14 89.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.183 0.993 . . . . 0.0 111.457 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.62 -35.8 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 0.0 111.038 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.92 -41.15 74.15 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.99 -1.069 . . . . 0.0 112.768 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.13 -42.7 86.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.024 0.929 . . . . 0.0 112.224 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.78 -42.43 79.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.894 0.878 . . . . 0.0 112.256 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.0 -27.86 20.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.109 2.164 . . . . 0.0 112.951 -176.37 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -63.34 -38.01 89.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.231 1.413 . . . . 0.0 112.194 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -65.61 153.43 41.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.498 1.919 . . . . 0.0 111.401 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -106.29 147.35 29.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.488 1.115 . . . . 0.0 111.275 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -55.21 -27.05 43.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.465 1.106 . . . . 0.0 113.073 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.09 -24.91 57.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.657 1.983 . . . . 0.0 112.965 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -104.09 -40.14 6.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.861 1.664 . . . . 0.0 111.254 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -59.09 -27.67 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.137 -0.977 . . . . 0.0 112.433 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -55.71 -27.37 50.01 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.822 -1.173 . . . . 0.0 112.42 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -65.23 -29.7 70.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.194 -0.941 . . . . 0.0 112.011 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -79.72 -35.24 39.2 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.359 1.064 . . . . 0.0 111.362 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.09 -48.53 67.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.431 1.492 . . . . 0.0 111.65 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -78.03 -27.69 48.85 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -66.83 -37.79 85.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.173 -0.954 . . . . 0.0 112.386 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mt -61.85 -33.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.138 -0.976 . . . . 0.0 110.93 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -62.15 -25.11 67.57 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.874 -1.141 . . . . 0.0 112.817 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.7 mt -64.3 -37.54 87.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.216 0.916 . . . . 0.0 111.826 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.85 -44.42 78.02 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.499 0.719 . . . . 0.0 111.019 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -84.05 -13.91 51.91 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mttt . . . . . 0 C--O 1.253 1.279 0 C-N-CA 128.968 2.907 . . . . 0.0 114.418 -171.839 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -67.29 96.38 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.276 1.831 . . . . 0.0 112.101 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 163.82 18.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.514 1.126 . . . . 0.0 110.57 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.13 168.85 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.419 1.488 . . . . 0.0 111.215 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -58.54 -28.71 65.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 112.674 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -38.74 80.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.621 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.3 -35.2 79.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 112.199 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.4 -53.49 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.067 0.947 . . . . 0.0 111.052 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 t -63.52 -25.42 68.24 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.28 -43.01 92.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.64 1.176 . . . . 0.0 111.537 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -69.11 -33.27 73.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.601 -0.687 . . . . 0.0 112.831 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -36.3 80.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.406 0.682 . . . . 0.0 111.717 174.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -39.07 78.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.898 0.879 . . . . 0.0 112.784 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.12 -41.21 92.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.05 0.94 . . . . 0.0 113.098 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.1 mt -62.16 -53.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.361 1.064 . . . . 0.0 110.636 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -57.32 -45.49 84.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.756 1.223 . . . . 0.0 112.478 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.09 -48.23 79.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.428 1.491 . . . . 0.0 111.876 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -56.14 -48.93 75.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.673 0.669 . . . . 0.0 111.58 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -28.2 26.6 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.563 1.545 . . . . 0.0 113.658 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -113.84 117.66 32.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.96 1.704 . . . . 0.0 110.878 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -66.83 169.88 7.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.239 1.815 . . . . 0.0 111.435 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -122.52 156.88 33.24 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.714 1.206 . . . . 0.0 111.813 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.5 p-90 -59.63 -28.58 67.33 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.247 1.019 . . . . 0.0 113.178 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -30.89 71.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.171 0.989 . . . . 0.0 112.936 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.92 -27.57 63.88 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.938 -1.101 . . . . 0.0 111.603 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.2 mm -65.49 -37.03 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.963 1.305 . . . . 0.0 111.581 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -61.06 -34.32 74.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.262 0.937 . . . . 0.0 112.224 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.77 -47.5 84.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.353 1.461 . . . . 0.0 111.556 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -71.02 -41.4 70.92 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.689 1.196 . . . . 0.0 112.963 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 66.3 mt -60.11 -34.85 74.05 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.073 0.949 . . . . 0.0 112.66 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.11 97.39 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.691 -0.631 . . . . 0.0 112.19 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -57.38 -28.25 63.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.293 1.037 . . . . 0.0 113.322 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.66 -43.9 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.305 1.042 . . . . 0.0 111.593 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -74.1 -34.67 64.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.255 . . . . 0.0 112.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.83 -38.41 78.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.783 0.833 . . . . 0.0 111.831 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.901 0.773 . . . . 0.0 111.552 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.54 -33.75 17.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.17 1.788 . . . . 0.0 113.211 178.599 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 119.818 -0.134 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -67.72 131.95 46.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.847 0.859 . . . . 0.0 111.79 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -126.71 -78.32 0.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.16 1.784 . . . . 0.0 111.008 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.15 171.58 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.526 1.93 . . . . 0.0 110.306 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -51.56 -21.69 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.056 1.742 . . . . 0.0 114.774 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.9 -21.15 63.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.76 1.224 . . . . 0.0 112.34 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -23.06 67.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.498 -1.376 . . . . 0.0 112.87 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -68.29 -43.22 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.756 1.222 . . . . 0.0 110.946 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -70.34 -23.21 62.78 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.136 -0.978 . . . . 0.0 112.961 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.63 -38.47 81.44 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.956 0.902 . . . . 0.0 111.726 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -66.51 -46.84 74.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.25 1.02 . . . . 0.0 111.801 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.55 -41.53 69.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.794 1.237 . . . . 0.0 112.224 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.15 -43.73 82.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.289 0.636 . . . . 0.0 111.874 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.18 -40.54 90.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.708 0.803 . . . . 0.0 112.295 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.8 mt -57.51 -52.35 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.117 0.967 . . . . 0.0 110.785 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -68.41 -37.18 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -58.35 -39.69 80.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.631 1.172 . . . . 0.0 112.006 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -55.89 -43.9 77.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.704 0.684 . . . . 0.0 112.209 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -15.04 43.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 125.963 1.705 . . . . 0.0 113.125 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -73.28 117.45 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.339 1.856 . . . . 0.0 113.068 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.81 141.46 40.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.947 2.099 . . . . 0.0 109.702 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -76.72 148.21 36.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 111.159 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -61.83 -27.97 69.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.31 -0.869 . . . . 0.0 112.685 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.07 -30.29 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.13 0.972 . . . . 0.0 112.961 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.28 -22.12 66.29 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.052 -1.03 . . . . 0.0 112.492 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.88 -28.09 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.036 -1.04 . . . . 0.0 111.674 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -63.67 -33.54 75.85 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.003 -1.061 . . . . 0.0 112.765 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.45 -41.78 79.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -61.73 -40.6 95.66 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.121 0.968 . . . . 0.0 113.106 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -46.41 80.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 111.557 175.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -34.53 74.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.267 1.027 . . . . 0.0 113.433 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.96 -41.34 91.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.451 1.101 . . . . 0.0 112.5 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.2 -44.67 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.518 1.127 . . . . 0.0 110.434 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -57.06 -41.76 79.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.676 0.79 . . . . 0.0 111.831 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.32 -47.33 85.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.485 1.114 . . . . 0.0 112.079 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.56 -44.68 77.03 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.092 0.86 . . . . 0.0 112.31 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -28.14 32.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 130.857 3.663 . . . . 0.0 115.655 -174.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -136.96 119.79 16.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.51 1.924 . . . . 0.0 110.941 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -120.68 -66.4 1.06 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.045 1.738 . . . . 0.0 111.336 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -139.26 155.31 47.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.704 1.602 . . . . 0.0 111.324 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -58.21 -28.3 64.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.646 1.178 . . . . 0.0 113.255 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -55.46 -44.31 76.31 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.14 1.376 . . . . 0.0 112.231 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.43 -39.68 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.495 -0.753 . . . . 0.0 111.694 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.27 -51.46 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.393 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 t -66.66 -29.52 69.56 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.346 -0.846 . . . . 0.0 113.157 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.69 -43.61 90.06 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -68.8 -33.16 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.54 -35.25 75.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.482 1.113 . . . . 0.0 112.034 176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -29.88 71.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.213 1.005 . . . . 0.0 113.708 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.34 -41.71 85.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.249 1.02 . . . . 0.0 112.076 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.36 -41.56 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.061 0.944 . . . . 0.0 110.742 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -63.67 -38.2 90.21 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.94 0.896 . . . . 0.0 113.306 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.92 -38.15 81.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.853 0.751 . . . . 0.0 112.618 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -56.06 -41.64 75.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.098 0.863 . . . . 0.0 112.334 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -30.09 31.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mttm . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 130.03 3.332 . . . . 0.0 115.599 -168.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -126.33 89.75 3.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.174 1.39 . . . . 0.0 111.249 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -65.16 -62.09 1.75 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.65 1.18 . . . . 0.0 112.422 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -153.15 160.38 42.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 110.984 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.88 -35.19 77.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.687 0.795 . . . . 0.0 112.882 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -61.91 -31.23 71.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.699 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.89 -27.62 66.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.552 1.141 . . . . 0.0 111.954 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -72.05 -45.97 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.27 1.028 . . . . 0.0 110.565 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.8 p -63.48 -21.38 66.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -58.17 -37.23 74.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.987 1.315 . . . . 0.0 111.235 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -75.02 -38.05 61.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 113.216 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.05 -41.45 71.44 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.368 0.985 . . . . 0.0 112.252 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -37.91 76.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 112.44 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.03 -41.47 96.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.723 1.209 . . . . 0.0 112.948 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mt -68.14 -45.83 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.683 0.793 . . . . 0.0 110.694 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -56.32 -39.57 72.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.448 1.099 . . . . 0.0 113.224 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.37 -43.22 96.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.601 0.76 . . . . 0.0 111.527 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -56.43 -41.51 76.54 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.153 0.888 . . . . 0.0 112.595 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -18.91 23.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 126.349 1.859 . . . . 0.0 112.77 177.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 ptmm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -135.98 150.75 49.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.851 1.66 . . . . 0.0 111.32 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -66.14 1.02 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.685 1.594 . . . . 0.0 111.127 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.12 164.43 34.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.488 1.115 . . . . 0.0 111.635 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -60.72 -30.26 69.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.765 0.826 . . . . 0.0 112.919 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.35 -29.2 69.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.802 1.241 . . . . 0.0 113.141 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.19 -42.09 93.91 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.861 -1.15 . . . . 0.0 110.316 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.4 mm -63.17 -45.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 111.832 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -63.07 -28.36 70.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.99 -42.01 94.9 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.081 0.855 . . . . 0.0 110.998 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -67.68 -35.07 78.16 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.631 0.772 . . . . 0.0 112.131 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -29.59 68.7 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.764 . . . . 0.0 112.201 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -30.77 70.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.895 0.878 . . . . 0.0 113.077 175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.136 0.974 . . . . 0.0 112.244 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.8 mm -64.38 -43.49 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -64.8 -37.55 87.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.925 0.89 . . . . 0.0 112.886 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.37 -46.45 76.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.154 0.888 . . . . 0.0 111.541 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -55.44 -43.11 75.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.411 0.685 . . . . 0.0 112.354 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -28.47 25.01 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.4 mttp . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 130.604 3.562 . . . . 0.0 117.605 -177.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt . . . . . 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 66.2 t80 . . . . . 0 N--CA 1.471 0.575 0 CA-C-O 119.885 -0.102 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' A' ' 18' ' ' PHE . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -117.92 9.82 12.97 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.349 1.86 . . . . 0.0 113.791 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -86.21 161.2 18.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.191 2.196 . . . . 0.0 112.078 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -143.67 167.23 22.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.345 1.858 . . . . 0.0 110.87 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -53.53 -31.07 44.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.897 1.279 . . . . 0.0 113.265 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.75 -22.99 66.97 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.197 1.399 . . . . 0.0 113.328 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.57 -23.87 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.095 1.358 . . . . 0.0 112.389 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -61.57 -28.22 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.774 -1.203 . . . . 0.0 112.114 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 t -58.12 -31.44 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.013 -1.054 . . . . 0.0 113.593 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.99 -43.41 92.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.322 1.049 . . . . 0.0 111.641 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -62.44 -43.54 98.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.735 0.814 . . . . 0.0 111.54 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -45.1 72.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.869 0.868 . . . . 0.0 111.585 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -34.93 70.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.359 1.064 . . . . 0.0 113.513 175.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -58.54 -45.15 89.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.02 . . . . 0.0 112.026 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.33 -37.16 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.712 -0.618 . . . . 0.0 110.594 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.8 -41.17 77.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.248 1.019 . . . . 0.0 112.144 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -58.33 -42.76 87.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.777 1.231 . . . . 0.0 112.527 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.38 -39.7 70.44 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.872 0.76 . . . . 0.0 112.279 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.2 -28.78 23.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.514 1.926 . . . . 0.0 114.464 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.1 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -117.6 17.1 14.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.716 2.006 . . . . 0.0 114.308 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -87.33 127.43 35.19 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.766 1.627 . . . . 0.0 111.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -69.59 138.35 53.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.785 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -57.32 -29.72 64.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.969 0.908 . . . . 0.0 113.254 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.79 -27.44 69.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.89 -32.27 34.9 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 0.0 111.798 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -57.6 -48.0 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.501 1.12 . . . . 0.0 111.507 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -63.38 -28.99 70.37 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.575 -0.703 . . . . 0.0 112.55 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -68.28 -34.3 75.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.263 0.938 . . . . 0.0 110.838 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -72.12 -35.65 69.21 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.096 -1.003 . . . . 0.0 112.828 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -49.87 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.168 0.987 . . . . 0.0 113.195 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.624 ' CZ3' HD22 ' A' ' 17' ' ' LEU . 37.4 p-90 -77.2 -31.87 55.59 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -63.44 -36.44 83.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.584 1.153 . . . . 0.0 112.991 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.1 mt -59.89 -53.78 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.114 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -65.41 -31.72 72.96 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.24 1.016 . . . . 0.0 113.522 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' CZ3' ' A' ' 13' ' ' TRP . 46.8 tp -58.2 -44.91 88.32 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.448 1.099 . . . . 0.0 110.344 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -55.29 -46.66 76.21 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.065 -0.397 . . . . 0.0 111.411 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -85.03 -29.64 24.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.792 1.637 . . . . 0.0 112.898 -177.692 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.39 0.138 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -129.0 122.42 30.04 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.565 1.946 . . . . 0.0 110.212 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -125.37 172.53 9.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.665 2.386 . . . . 0.0 110.666 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.49 162.53 15.12 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.842 0.857 . . . . 0.0 112.149 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -58.14 -29.13 65.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.002 -1.061 . . . . 0.0 113.254 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -61.22 -29.04 69.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.304 1.442 . . . . 0.0 113.204 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.24 -25.77 36.37 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 0.0 111.194 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -73.57 -41.57 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.203 1.001 . . . . 0.0 110.85 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -60.95 -28.09 68.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.258 -0.901 . . . . 0.0 112.947 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.6 -43.27 90.17 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.566 0.746 . . . . 0.0 110.887 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.72 -34.05 76.98 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.248 -0.907 . . . . 0.0 113.148 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 -49.8 65.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 112.835 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -76.05 -28.63 57.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -65.95 -42.3 90.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.763 0.825 . . . . 0.0 112.314 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -57.61 -34.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 0.0 110.888 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.31 -26.17 66.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.543 1.537 . . . . 0.0 113.443 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.99 -39.71 93.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.883 0.873 . . . . 0.0 111.105 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.88 -43.94 86.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.748 -0.595 . . . . 0.0 110.719 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -19.81 27.5 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.637 1.575 . . . . 0.0 112.401 177.198 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.507 0.194 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -154.26 73.1 0.91 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.705 1.202 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -124.32 -69.87 0.78 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 111.381 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.58 142.96 21.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.378 1.471 . . . . 0.0 110.287 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -61.04 -33.82 73.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.381 0.672 . . . . 0.0 112.291 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -73.43 -28.66 62.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.124 0.97 . . . . 0.0 112.945 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.38 -19.56 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.751 -1.218 . . . . 0.0 112.746 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.82 -25.47 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.705 1.202 . . . . 0.0 112.429 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -62.36 -29.65 70.62 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.592 -1.317 . . . . 0.0 112.24 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.58 -35.45 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.762 1.225 . . . . 0.0 112.454 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -63.7 -38.73 92.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.626 0.77 . . . . 0.0 111.699 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.27 -36.27 65.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.198 0.999 . . . . 0.0 111.647 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -54.83 -48.19 73.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.703 0.801 . . . . 0.0 112.156 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -65.27 -43.81 90.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.496 0.718 . . . . 0.0 112.061 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 mt -56.34 -55.22 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.98 0.912 . . . . 0.0 110.599 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.53 87.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.662 1.185 . . . . 0.0 112.447 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.96 -43.85 91.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.984 1.313 . . . . 0.0 111.083 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -56.08 -45.0 79.5 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.682 -0.636 . . . . 0.0 111.236 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.12 -25.11 27.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.95 93.68 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.223 1.409 . . . . 0.0 112.097 -173.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -125.92 -76.23 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.045 2.538 . . . . 0.0 110.763 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -135.02 157.6 46.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.349 1.859 . . . . 0.0 110.858 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -57.37 -27.86 62.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.314 1.046 . . . . 0.0 113.134 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -23.0 63.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 113.465 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.24 -38.74 10.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.782 0.833 . . . . 0.0 111.012 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.96 -42.9 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.314 1.046 . . . . 0.0 111.51 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -60.03 -31.88 70.37 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.931 0.787 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -69.91 -48.52 58.24 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.571 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -61.39 -38.53 87.38 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.09 -36.47 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.983 0.913 . . . . 0.0 112.208 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -36.97 80.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.39 1.476 . . . . 0.0 113.656 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -61.02 -45.77 93.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 111.659 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' H ' HD12 ' A' ' 15' ' ' ILE . 4.5 mp -66.8 -43.86 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.808 -0.557 . . . . 0.0 109.696 174.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -55.61 -37.88 68.72 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.236 1.014 . . . . 0.0 113.088 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -58.84 -44.23 90.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.73 0.812 . . . . 0.0 111.298 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.83 -46.8 88.11 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.727 -0.608 . . . . 0.0 110.762 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -12.42 59.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.848 2.459 . . . . 0.0 113.457 -171.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.908 -0.567 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -88.02 -16.27 34.12 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.51 173.99 3.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.842 1.257 . . . . 0.0 112.265 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.74 132.76 54.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.71 0.804 . . . . 0.0 111.624 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -55.35 -29.79 59.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.526 1.13 . . . . 0.0 113.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -31.51 67.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.095 1.758 . . . . 0.0 113.315 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.2 -33.27 33.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.07 -1.019 . . . . 0.0 111.177 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.38 -39.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.918 1.287 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -61.94 -32.33 72.74 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.086 -1.009 . . . . 0.0 112.597 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -61.76 -39.33 91.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.821 0.737 . . . . 0.0 111.884 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -64.24 -45.67 87.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.801 0.728 . . . . 0.0 111.616 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -41.77 92.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.966 0.906 . . . . 0.0 112.58 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -34.39 77.51 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.694 -0.629 . . . . 0.0 112.535 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.5 -25.75 67.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.861 0.865 . . . . 0.0 113.036 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.66 -48.04 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.881 1.272 . . . . 0.0 110.731 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -70.56 -32.3 69.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.377 1.071 . . . . 0.0 112.693 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.85 -39.51 89.4 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.727 0.811 . . . . 0.0 110.995 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.17 -45.97 75.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.359 0.981 . . . . 0.0 111.69 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -85.47 -27.44 25.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.995 1.718 . . . . 0.0 113.132 -175.505 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.141 0.496 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.51 114.05 26.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.639 1.575 . . . . 0.0 110.689 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -127.33 -66.08 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.59 1.556 . . . . 0.0 112.455 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -148.77 176.76 10.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.036 1.735 . . . . 0.0 111.17 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -52.02 -29.74 22.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 113.359 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.84 -35.32 66.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.514 1.526 . . . . 0.0 112.744 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -33.11 55.1 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.246 -0.909 . . . . 0.0 111.749 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.6 -33.22 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.924 0.89 . . . . 0.0 112.108 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -62.31 -29.3 70.34 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.78 -1.2 . . . . 0.0 113.455 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.93 -43.2 88.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.914 0.885 . . . . 0.0 111.182 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.97 -42.11 97.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.537 0.735 . . . . 0.0 112.129 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -54.98 -39.02 68.54 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.21 0.604 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -43.78 86.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.237 1.015 . . . . 0.0 113.073 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -58.12 -43.54 87.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.182 0.993 . . . . 0.0 112.229 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -68.97 -41.64 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.665 0.786 . . . . 0.0 110.801 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -36.15 65.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.985 1.314 . . . . 0.0 113.2 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.14 -43.67 98.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.51 0.724 . . . . 0.0 111.158 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.26 -45.5 93.07 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.428 -0.795 . . . . 0.0 110.83 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -26.02 22.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.839 2.056 . . . . 0.0 112.585 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -56.81 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.773 1.629 . . . . 0.0 112.642 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.93 153.81 50.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.827 2.051 . . . . 0.0 110.876 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.52 139.63 55.64 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.192 0.997 . . . . 0.0 110.192 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -55.64 -30.5 61.08 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 112.92 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -38.2 84.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.768 1.227 . . . . 0.0 112.16 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -32.4 65.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.669 1.188 . . . . 0.0 112.482 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.58 -27.42 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 0.0 111.926 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -58.78 -35.27 72.52 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.016 -1.053 . . . . 0.0 113.167 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -44.07 88.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 111.801 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -64.39 -41.87 96.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.25 1.02 . . . . 0.0 112.178 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.22 -40.48 94.15 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.778 0.831 . . . . 0.0 112.111 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -28.17 69.89 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.11 -28.63 63.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.186 -0.946 . . . . 0.0 113.192 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.38 -41.51 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.418 1.087 . . . . 0.0 110.395 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -36.44 79.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 112.116 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.75 -39.78 81.95 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.994 0.918 . . . . 0.0 112.733 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -54.16 -45.26 72.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.387 0.994 . . . . 0.0 111.903 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 -21.13 29.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.469 1.508 . . . . 0.0 112.125 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 91.13 7.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.797 1.181 . . . . 0.0 111.633 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -122.76 168.77 11.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.106 1.362 . . . . 0.0 112.375 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -68.21 162.02 25.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.412 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -56.37 -29.21 61.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.886 0.874 . . . . 0.0 113.261 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -62.6 -28.03 69.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.816 1.647 . . . . 0.0 113.087 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -84.68 -39.92 18.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.757 1.223 . . . . 0.0 111.096 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.28 -48.4 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.198 0.999 . . . . 0.0 110.799 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -58.89 -31.85 68.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -60.52 -44.57 95.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.58 1.082 . . . . 0.0 112.059 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.14 -42.29 66.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.618 0.767 . . . . 0.0 111.575 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.65 -29.37 70.02 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.593 0.757 . . . . 0.0 112.423 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -33.18 68.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.404 1.081 . . . . 0.0 113.389 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -67.32 -25.89 66.24 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.329 -0.857 . . . . 0.0 113.218 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mm -59.89 -40.87 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.094 -1.004 . . . . 0.0 110.516 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -70.98 -32.06 68.8 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.335 1.054 . . . . 0.0 112.84 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.17 -44.54 92.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.953 0.797 . . . . 0.0 111.236 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.25 -43.99 75.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.93 0.492 . . . . 0.0 111.875 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -18.87 30.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.987 2.115 . . . . 0.0 111.799 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.4 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.82 124.96 23.35 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.024 0.929 . . . . 0.0 111.291 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.16 170.2 14.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.641 1.177 . . . . 0.0 112.16 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.01 152.25 35.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.91 1.684 . . . . 0.0 111.959 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -53.49 -26.64 21.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.629 1.571 . . . . 0.0 114.128 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -24.15 59.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.929 1.691 . . . . 0.0 113.468 175.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -82.59 -42.71 17.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.772 1.229 . . . . 0.0 111.448 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.1 mm -62.41 -46.33 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.916 1.286 . . . . 0.0 110.855 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -61.49 -29.49 70.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -44.6 94.54 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.188 0.995 . . . . 0.0 111.664 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -70.95 -42.75 69.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.141 0.976 . . . . 0.0 111.93 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.77 -29.07 69.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -32.7 71.01 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.217 -0.927 . . . . 0.0 112.853 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.76 -27.01 67.26 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.45 -38.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.009 -1.057 . . . . 0.0 111.034 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.25 -28.86 61.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.609 -0.682 . . . . 0.0 112.665 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.99 -39.68 95.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.99 0.916 . . . . 0.0 111.654 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.1 -45.4 71.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.496 0.718 . . . . 0.0 111.609 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -13.74 35.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.814 2.045 . . . . 0.0 112.932 178.528 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -74.35 53.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.097 1.759 . . . . 0.0 113.09 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -71.19 168.24 17.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.944 1.698 . . . . 0.0 111.411 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.64 161.7 14.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 112.628 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -58.34 -33.65 69.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 112.849 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -36.49 83.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.108 0.963 . . . . 0.0 112.083 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -21.31 63.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.337 1.055 . . . . 0.0 112.848 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.27 -20.69 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.114 0.966 . . . . 0.0 110.942 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -57.78 -32.49 67.56 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.141 -0.974 . . . . 0.0 111.608 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -36.95 78.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.971 0.908 . . . . 0.0 112.148 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.1 -35.0 64.14 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.548 -0.72 . . . . 0.0 112.412 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -49.72 54.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.587 1.555 . . . . 0.0 112.619 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -77.63 -28.18 51.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.26 -39.31 93.68 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.106 -0.996 . . . . 0.0 112.342 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.7 mt -60.17 -30.38 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.121 0.968 . . . . 0.0 111.525 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.08 -36.16 78.92 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.792 -1.193 . . . . 0.0 111.665 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.9 mt -58.14 -40.81 82.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.117 0.967 . . . . 0.0 111.783 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -56.3 -44.8 80.21 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.714 0.806 . . . . 0.0 111.608 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -81.1 -8.47 59.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.412 2.685 . . . . 0.0 113.141 -176.61 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -65.38 141.74 58.45 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.079 -1.638 . . . . 0.0 111.667 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.06 -71.46 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.041 . . . . 0.0 111.008 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -155.41 139.1 16.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.492 1.517 . . . . 0.0 110.213 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -55.85 -31.44 62.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.357 1.063 . . . . 0.0 113.26 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.97 63.87 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.34 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -85.22 -23.59 28.2 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.213 -0.929 . . . . 0.0 112.665 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.77 -24.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.235 1.414 . . . . 0.0 112.171 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -55.45 -32.42 62.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.072 -1.017 . . . . 0.0 113.494 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -60.76 -42.5 97.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.247 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -66.82 -43.41 83.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 111.472 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -58.94 -43.56 91.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.782 0.833 . . . . 0.0 111.696 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -33.47 73.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 112.951 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.56 -45.14 89.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.183 0.993 . . . . 0.0 111.457 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.62 -35.8 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 0.0 111.038 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.92 -41.15 74.15 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.99 -1.069 . . . . 0.0 112.768 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.13 -42.7 86.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.024 0.929 . . . . 0.0 112.224 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.78 -42.43 79.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.894 0.878 . . . . 0.0 112.256 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.0 -27.86 20.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.109 2.164 . . . . 0.0 112.951 -176.37 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -63.34 -38.01 89.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.231 1.413 . . . . 0.0 112.194 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -65.61 153.43 41.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.498 1.919 . . . . 0.0 111.401 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -106.29 147.35 29.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.488 1.115 . . . . 0.0 111.275 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -55.21 -27.05 43.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.465 1.106 . . . . 0.0 113.073 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.09 -24.91 57.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.657 1.983 . . . . 0.0 112.965 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -104.09 -40.14 6.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.861 1.664 . . . . 0.0 111.254 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -59.09 -27.67 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.137 -0.977 . . . . 0.0 112.433 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -55.71 -27.37 50.01 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.822 -1.173 . . . . 0.0 112.42 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -65.23 -29.7 70.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.194 -0.941 . . . . 0.0 112.011 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -79.72 -35.24 39.2 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.359 1.064 . . . . 0.0 111.362 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.09 -48.53 67.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.431 1.492 . . . . 0.0 111.65 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -78.03 -27.69 48.85 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -66.83 -37.79 85.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.173 -0.954 . . . . 0.0 112.386 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mt -61.85 -33.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.138 -0.976 . . . . 0.0 110.93 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -62.15 -25.11 67.57 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.874 -1.141 . . . . 0.0 112.817 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.7 mt -64.3 -37.54 87.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.216 0.916 . . . . 0.0 111.826 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 66.2 t80 -55.85 -44.42 78.02 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.499 0.719 . . . . 0.0 111.019 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' A' ' 18' ' ' PHE . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -84.05 -13.91 51.91 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mttt . . . . . 0 C--O 1.253 1.279 0 C-N-CA 128.968 2.907 . . . . 0.0 114.418 -171.839 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -67.29 96.38 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.276 1.831 . . . . 0.0 112.101 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 163.82 18.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.514 1.126 . . . . 0.0 110.57 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.13 168.85 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.419 1.488 . . . . 0.0 111.215 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -58.54 -28.71 65.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 112.674 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -38.74 80.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.621 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.3 -35.2 79.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 112.199 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.4 -53.49 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.067 0.947 . . . . 0.0 111.052 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 t -63.52 -25.42 68.24 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.28 -43.01 92.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.64 1.176 . . . . 0.0 111.537 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -69.11 -33.27 73.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.601 -0.687 . . . . 0.0 112.831 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -36.3 80.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.406 0.682 . . . . 0.0 111.717 174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -39.07 78.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.898 0.879 . . . . 0.0 112.784 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.12 -41.21 92.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.05 0.94 . . . . 0.0 113.098 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.1 mt -62.16 -53.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.361 1.064 . . . . 0.0 110.636 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -57.32 -45.49 84.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.756 1.223 . . . . 0.0 112.478 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.09 -48.23 79.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.428 1.491 . . . . 0.0 111.876 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -56.14 -48.93 75.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.673 0.669 . . . . 0.0 111.58 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -28.2 26.6 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.563 1.545 . . . . 0.0 113.658 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -113.84 117.66 32.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.96 1.704 . . . . 0.0 110.878 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -66.83 169.88 7.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.239 1.815 . . . . 0.0 111.435 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -122.52 156.88 33.24 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.714 1.206 . . . . 0.0 111.813 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.5 p-90 -59.63 -28.58 67.33 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.247 1.019 . . . . 0.0 113.178 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -30.89 71.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.171 0.989 . . . . 0.0 112.936 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.92 -27.57 63.88 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.938 -1.101 . . . . 0.0 111.603 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.2 mm -65.49 -37.03 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.963 1.305 . . . . 0.0 111.581 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -61.06 -34.32 74.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.262 0.937 . . . . 0.0 112.224 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.77 -47.5 84.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.353 1.461 . . . . 0.0 111.556 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -71.02 -41.4 70.92 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.689 1.196 . . . . 0.0 112.963 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 66.3 mt -60.11 -34.85 74.05 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.073 0.949 . . . . 0.0 112.66 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.11 97.39 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.691 -0.631 . . . . 0.0 112.19 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -57.38 -28.25 63.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.293 1.037 . . . . 0.0 113.322 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.66 -43.9 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.305 1.042 . . . . 0.0 111.593 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -74.1 -34.67 64.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.255 . . . . 0.0 112.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.83 -38.41 78.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.783 0.833 . . . . 0.0 111.831 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.901 0.773 . . . . 0.0 111.552 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.54 -33.75 17.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.17 1.788 . . . . 0.0 113.211 178.599 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 119.818 -0.134 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -67.72 131.95 46.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.847 0.859 . . . . 0.0 111.79 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -126.71 -78.32 0.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.16 1.784 . . . . 0.0 111.008 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.15 171.58 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.526 1.93 . . . . 0.0 110.306 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -51.56 -21.69 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.056 1.742 . . . . 0.0 114.774 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.9 -21.15 63.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.76 1.224 . . . . 0.0 112.34 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -23.06 67.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.498 -1.376 . . . . 0.0 112.87 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -68.29 -43.22 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.756 1.222 . . . . 0.0 110.946 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -70.34 -23.21 62.78 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.136 -0.978 . . . . 0.0 112.961 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.63 -38.47 81.44 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.956 0.902 . . . . 0.0 111.726 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -66.51 -46.84 74.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.25 1.02 . . . . 0.0 111.801 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.8 mt -54.55 -41.53 69.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.794 1.237 . . . . 0.0 112.224 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.15 -43.73 82.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.289 0.636 . . . . 0.0 111.874 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.18 -40.54 90.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.708 0.803 . . . . 0.0 112.295 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 12' ' ' LEU . 41.8 mt -57.51 -52.35 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.117 0.967 . . . . 0.0 110.785 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -68.41 -37.18 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -58.35 -39.69 80.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.631 1.172 . . . . 0.0 112.006 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -55.89 -43.9 77.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.704 0.684 . . . . 0.0 112.209 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -15.04 43.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 125.963 1.705 . . . . 0.0 113.125 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -73.28 117.45 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.339 1.856 . . . . 0.0 113.068 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.81 141.46 40.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.947 2.099 . . . . 0.0 109.702 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -76.72 148.21 36.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 111.159 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -61.83 -27.97 69.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.31 -0.869 . . . . 0.0 112.685 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.07 -30.29 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.13 0.972 . . . . 0.0 112.961 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.28 -22.12 66.29 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.052 -1.03 . . . . 0.0 112.492 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.88 -28.09 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.036 -1.04 . . . . 0.0 111.674 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -63.67 -33.54 75.85 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.003 -1.061 . . . . 0.0 112.765 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.45 -41.78 79.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -61.73 -40.6 95.66 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.121 0.968 . . . . 0.0 113.106 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -46.41 80.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 111.557 175.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -34.53 74.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.267 1.027 . . . . 0.0 113.433 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.96 -41.34 91.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.451 1.101 . . . . 0.0 112.5 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.2 -44.67 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.518 1.127 . . . . 0.0 110.434 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -57.06 -41.76 79.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.676 0.79 . . . . 0.0 111.831 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.32 -47.33 85.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.485 1.114 . . . . 0.0 112.079 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.56 -44.68 77.03 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.092 0.86 . . . . 0.0 112.31 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -28.14 32.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 130.857 3.663 . . . . 0.0 115.655 -174.908 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -136.96 119.79 16.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.51 1.924 . . . . 0.0 110.941 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -120.68 -66.4 1.06 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.045 1.738 . . . . 0.0 111.336 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -139.26 155.31 47.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.704 1.602 . . . . 0.0 111.324 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -58.21 -28.3 64.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.646 1.178 . . . . 0.0 113.255 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -55.46 -44.31 76.31 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.14 1.376 . . . . 0.0 112.231 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.43 -39.68 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.495 -0.753 . . . . 0.0 111.694 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.27 -51.46 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.393 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 t -66.66 -29.52 69.56 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.346 -0.846 . . . . 0.0 113.157 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.69 -43.61 90.06 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -68.8 -33.16 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.54 -35.25 75.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.482 1.113 . . . . 0.0 112.034 176.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -29.88 71.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.213 1.005 . . . . 0.0 113.708 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.34 -41.71 85.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.249 1.02 . . . . 0.0 112.076 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.36 -41.56 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.061 0.944 . . . . 0.0 110.742 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -63.67 -38.2 90.21 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.94 0.896 . . . . 0.0 113.306 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.92 -38.15 81.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.853 0.751 . . . . 0.0 112.618 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -56.06 -41.64 75.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.098 0.863 . . . . 0.0 112.334 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -30.09 31.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mttm . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 130.03 3.332 . . . . 0.0 115.599 -168.95 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -126.33 89.75 3.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.174 1.39 . . . . 0.0 111.249 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -65.16 -62.09 1.75 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.65 1.18 . . . . 0.0 112.422 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -153.15 160.38 42.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 110.984 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.88 -35.19 77.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.687 0.795 . . . . 0.0 112.882 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -61.91 -31.23 71.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.699 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.89 -27.62 66.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.552 1.141 . . . . 0.0 111.954 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -72.05 -45.97 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.27 1.028 . . . . 0.0 110.565 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.8 p -63.48 -21.38 66.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -58.17 -37.23 74.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.987 1.315 . . . . 0.0 111.235 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -75.02 -38.05 61.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 113.216 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.05 -41.45 71.44 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.368 0.985 . . . . 0.0 112.252 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -37.91 76.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 112.44 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.03 -41.47 96.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.723 1.209 . . . . 0.0 112.948 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mt -68.14 -45.83 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.683 0.793 . . . . 0.0 110.694 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -56.32 -39.57 72.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.448 1.099 . . . . 0.0 113.224 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.37 -43.22 96.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.601 0.76 . . . . 0.0 111.527 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -56.43 -41.51 76.54 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.153 0.888 . . . . 0.0 112.595 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -18.91 23.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 126.349 1.859 . . . . 0.0 112.77 177.202 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 ptmm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -135.98 150.75 49.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.851 1.66 . . . . 0.0 111.32 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -66.14 1.02 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.685 1.594 . . . . 0.0 111.127 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.12 164.43 34.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.488 1.115 . . . . 0.0 111.635 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -60.72 -30.26 69.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.765 0.826 . . . . 0.0 112.919 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.35 -29.2 69.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.802 1.241 . . . . 0.0 113.141 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.19 -42.09 93.91 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.861 -1.15 . . . . 0.0 110.316 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.4 mm -63.17 -45.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 111.832 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -63.07 -28.36 70.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.99 -42.01 94.9 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.081 0.855 . . . . 0.0 110.998 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -67.68 -35.07 78.16 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.631 0.772 . . . . 0.0 112.131 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -29.59 68.7 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.764 . . . . 0.0 112.201 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -30.77 70.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.895 0.878 . . . . 0.0 113.077 175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.136 0.974 . . . . 0.0 112.244 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.8 mm -64.38 -43.49 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -64.8 -37.55 87.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.925 0.89 . . . . 0.0 112.886 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.37 -46.45 76.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.154 0.888 . . . . 0.0 111.541 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -55.44 -43.11 75.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.411 0.685 . . . . 0.0 112.354 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -28.47 25.01 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.4 mttp . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 130.604 3.562 . . . . 0.0 117.605 -177.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.452 -0.308 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt . . . . . 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 66.2 t80 . . . . . 0 N--CA 1.471 0.575 0 CA-C-O 119.885 -0.102 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' A' ' 18' ' ' PHE . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -117.92 9.82 12.97 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.349 1.86 . . . . 0.0 113.791 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -86.21 161.2 18.93 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.191 2.196 . . . . 0.0 112.078 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -143.67 167.23 22.75 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.345 1.858 . . . . 0.0 110.87 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -53.53 -31.07 44.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.897 1.279 . . . . 0.0 113.265 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.75 -22.99 66.97 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.197 1.399 . . . . 0.0 113.328 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.57 -23.87 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.095 1.358 . . . . 0.0 112.389 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mm -61.57 -28.22 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.774 -1.203 . . . . 0.0 112.114 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 t -58.12 -31.44 67.16 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.013 -1.054 . . . . 0.0 113.593 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.99 -43.41 92.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.322 1.049 . . . . 0.0 111.641 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -62.44 -43.54 98.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.735 0.814 . . . . 0.0 111.54 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.29 -45.1 72.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.869 0.868 . . . . 0.0 111.585 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -34.93 70.71 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.359 1.064 . . . . 0.0 113.513 175.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -58.54 -45.15 89.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.249 1.02 . . . . 0.0 112.026 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.33 -37.16 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.712 -0.618 . . . . 0.0 110.594 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.8 -41.17 77.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.248 1.019 . . . . 0.0 112.144 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -58.33 -42.76 87.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.777 1.231 . . . . 0.0 112.527 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.38 -39.7 70.44 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.872 0.76 . . . . 0.0 112.279 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.08 -42.25 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.908 0.883 . . . . 0.0 111.115 175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.7 mtt -67.92 -45.64 73.77 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.63 -0.669 . . . . 0.0 112.231 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.91 -54.49 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.251 1.021 . . . . 0.0 110.164 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.29 -35.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.179 -0.95 . . . . 0.0 111.621 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.09 -24.56 51.31 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.454 1.025 . . . . 0.0 114.233 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.62 -25.7 6.8 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.452 1.501 . . . . 0.0 113.93 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -88.72 -14.95 35.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.016 1.408 . . . . 0.0 114.656 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.67 -32.21 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 120.992 -1.068 . . . . 0.0 112.329 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -86.2 -28.78 23.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.424 1.49 . . . . 0.0 114.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.514 1.926 . . . . 0.0 114.464 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.1 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -117.6 17.1 14.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 126.716 2.006 . . . . 0.0 114.308 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -87.33 127.43 35.19 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.766 1.627 . . . . 0.0 111.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -69.59 138.35 53.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.181 0.992 . . . . 0.0 110.785 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -57.32 -29.72 64.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.969 0.908 . . . . 0.0 113.254 175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -63.79 -27.44 69.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.955 1.302 . . . . 0.0 112.887 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.89 -32.27 34.9 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.179 0.992 . . . . 0.0 111.798 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -57.6 -48.0 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.501 1.12 . . . . 0.0 111.507 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -63.38 -28.99 70.37 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.575 -0.703 . . . . 0.0 112.55 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -68.28 -34.3 75.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.263 0.938 . . . . 0.0 110.838 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -72.12 -35.65 69.21 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.096 -1.003 . . . . 0.0 112.828 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.42 -49.87 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.168 0.987 . . . . 0.0 113.195 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.624 ' CZ3' HD22 ' A' ' 17' ' ' LEU . 37.4 p-90 -77.2 -31.87 55.59 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -63.44 -36.44 83.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.584 1.153 . . . . 0.0 112.991 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.1 mt -59.89 -53.78 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.114 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -65.41 -31.72 72.96 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.24 1.016 . . . . 0.0 113.522 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' CZ3' ' A' ' 13' ' ' TRP . 46.8 tp -58.2 -44.91 88.32 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.448 1.099 . . . . 0.0 110.344 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -55.29 -46.66 76.21 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.065 -0.397 . . . . 0.0 111.411 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.9 mt -59.81 -52.39 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.07 0.948 . . . . 0.0 111.553 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptp -61.48 -32.63 72.65 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.31 0.959 . . . . 0.0 113.113 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.46 -54.55 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.041 0.937 . . . . 0.0 110.065 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.02 -33.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.217 1.007 . . . . 0.0 111.65 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.3 -23.6 34.31 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.117 0.871 . . . . 0.0 114.539 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.87 -21.48 6.72 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 125.827 1.68 . . . . 0.0 114.299 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.7 mt -90.85 -19.62 23.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.26 1.53 . . . . 0.0 114.707 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.7 -34.35 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.356 1.062 . . . . 0.0 112.411 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -85.03 -29.64 24.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.651 1.58 . . . . 0.0 114.052 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? . . . . . 0 C--O 1.253 1.252 0 C-N-CA 125.792 1.637 . . . . 0.0 112.898 -177.692 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.39 0.138 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -129.0 122.42 30.04 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.565 1.946 . . . . 0.0 110.212 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -125.37 172.53 9.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.665 2.386 . . . . 0.0 110.666 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.49 162.53 15.12 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.842 0.857 . . . . 0.0 112.149 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -58.14 -29.13 65.32 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.002 -1.061 . . . . 0.0 113.254 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -61.22 -29.04 69.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.304 1.442 . . . . 0.0 113.204 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.24 -25.77 36.37 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.726 -1.234 . . . . 0.0 111.194 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -73.57 -41.57 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.203 1.001 . . . . 0.0 110.85 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -60.95 -28.09 68.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.258 -0.901 . . . . 0.0 112.947 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.6 -43.27 90.17 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.566 0.746 . . . . 0.0 110.887 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.72 -34.05 76.98 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.248 -0.907 . . . . 0.0 113.148 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.04 -49.8 65.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.203 1.001 . . . . 0.0 112.835 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -76.05 -28.63 57.73 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -65.95 -42.3 90.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.763 0.825 . . . . 0.0 112.314 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mt -57.61 -34.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 0.0 110.888 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -60.31 -26.17 66.34 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.543 1.537 . . . . 0.0 113.443 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.99 -39.71 93.87 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.883 0.873 . . . . 0.0 111.105 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.88 -43.94 86.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.748 -0.595 . . . . 0.0 110.719 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.59 -52.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.315 1.046 . . . . 0.0 111.499 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptm -61.11 -33.23 73.05 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.26 0.937 . . . . 0.0 113.419 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.89 -54.57 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.282 1.033 . . . . 0.0 110.25 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -58.92 -35.35 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.27 1.028 . . . . 0.0 111.475 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -22.37 36.81 Favored Glycine 0 CA--C 1.541 1.704 0 CA-C-N 119.006 0.821 . . . . 0.0 114.507 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.14 -20.85 6.9 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.91 1.719 . . . . 0.0 114.517 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 mt -89.75 -23.9 21.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.29 1.545 . . . . 0.0 114.317 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.79 -30.38 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.798 1.181 . . . . 0.0 112.644 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.45 -19.81 27.5 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.069 1.748 . . . . 0.0 114.554 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.637 1.575 . . . . 0.0 112.401 177.198 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.507 0.194 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -154.26 73.1 0.91 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.705 1.202 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -124.32 -69.87 0.78 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 111.381 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.58 142.96 21.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.378 1.471 . . . . 0.0 110.287 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -61.04 -33.82 73.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.381 0.672 . . . . 0.0 112.291 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -73.43 -28.66 62.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.124 0.97 . . . . 0.0 112.945 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.38 -19.56 63.83 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.751 -1.218 . . . . 0.0 112.746 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.82 -25.47 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.705 1.202 . . . . 0.0 112.429 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -62.36 -29.65 70.62 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.592 -1.317 . . . . 0.0 112.24 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.58 -35.45 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.762 1.225 . . . . 0.0 112.454 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -63.7 -38.73 92.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.626 0.77 . . . . 0.0 111.699 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.27 -36.27 65.92 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.198 0.999 . . . . 0.0 111.647 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -54.83 -48.19 73.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.703 0.801 . . . . 0.0 112.156 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -65.27 -43.81 90.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.496 0.718 . . . . 0.0 112.061 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 mt -56.34 -55.22 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.98 0.912 . . . . 0.0 110.599 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -37.53 87.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.662 1.185 . . . . 0.0 112.447 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.96 -43.85 91.39 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.984 1.313 . . . . 0.0 111.083 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -56.08 -45.0 79.5 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.682 -0.636 . . . . 0.0 111.236 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.73 -51.14 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 0.0 111.811 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptp -60.67 -33.37 72.73 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.421 1.009 . . . . 0.0 112.96 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.57 -54.3 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.942 0.897 . . . . 0.0 110.318 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.36 -34.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.07 0.948 . . . . 0.0 111.526 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.31 -23.89 35.38 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-N 119.221 0.919 . . . . 0.0 114.428 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.63 -20.38 7.75 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.854 1.692 . . . . 0.0 114.201 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.5 mt -92.11 -22.58 19.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.508 1.654 . . . . 0.0 114.37 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.34 -31.42 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.675 1.19 . . . . 0.0 112.417 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.12 -25.11 27.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.822 1.649 . . . . 0.0 114.236 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -66.95 93.68 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.223 1.409 . . . . 0.0 112.097 -173.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -125.92 -76.23 0.58 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.045 2.538 . . . . 0.0 110.763 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -135.02 157.6 46.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.349 1.859 . . . . 0.0 110.858 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -57.37 -27.86 62.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.314 1.046 . . . . 0.0 113.134 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -23.0 63.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.788 1.635 . . . . 0.0 113.465 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.24 -38.74 10.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.782 0.833 . . . . 0.0 111.012 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.96 -42.9 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.314 1.046 . . . . 0.0 111.51 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -60.03 -31.88 70.37 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.931 0.787 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -69.91 -48.52 58.24 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.571 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -61.39 -38.53 87.38 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.09 -36.47 63.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.983 0.913 . . . . 0.0 112.208 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -36.97 80.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.39 1.476 . . . . 0.0 113.656 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -61.02 -45.77 93.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.992 0.917 . . . . 0.0 111.659 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 HD12 ' H ' ' A' ' 15' ' ' ILE . 4.5 mp -66.8 -43.86 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.808 -0.557 . . . . 0.0 109.696 174.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmtp? -55.61 -37.88 68.72 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.236 1.014 . . . . 0.0 113.088 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -58.84 -44.23 90.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.73 0.812 . . . . 0.0 111.298 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -59.83 -46.8 88.11 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.727 -0.608 . . . . 0.0 110.762 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.3 mt -56.42 -52.21 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.618 0.767 . . . . 0.0 111.516 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ptm -63.25 -33.47 75.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.55 -54.64 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.007 0.923 . . . . 0.0 110.124 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.26 -36.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.685 1.194 . . . . 0.0 111.449 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.2 -22.16 35.38 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 124.14 0.876 . . . . 0.0 114.72 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.65 -22.44 7.02 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.552 1.548 . . . . 0.0 114.452 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.6 mt -87.74 -29.96 20.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.24 1.52 . . . . 0.0 114.001 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.29 -30.98 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.109 1.363 . . . . 0.0 112.951 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 -12.42 59.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.523 1.529 . . . . 0.0 114.476 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.848 2.459 . . . . 0.0 113.457 -171.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.908 -0.567 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -88.02 -16.27 34.12 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.51 173.99 3.73 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.842 1.257 . . . . 0.0 112.265 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.74 132.76 54.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.71 0.804 . . . . 0.0 111.624 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.6 p-90 -55.35 -29.79 59.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.526 1.13 . . . . 0.0 113.602 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -31.51 67.45 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.095 1.758 . . . . 0.0 113.315 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -81.2 -33.27 33.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.07 -1.019 . . . . 0.0 111.177 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.38 -39.4 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.918 1.287 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -61.94 -32.33 72.74 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.086 -1.009 . . . . 0.0 112.597 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -61.76 -39.33 91.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.821 0.737 . . . . 0.0 111.884 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -64.24 -45.67 87.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.801 0.728 . . . . 0.0 111.616 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -41.77 92.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.966 0.906 . . . . 0.0 112.58 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -34.39 77.51 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.694 -0.629 . . . . 0.0 112.535 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.5 -25.75 67.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.861 0.865 . . . . 0.0 113.036 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.5 mt -58.66 -48.04 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.881 1.272 . . . . 0.0 110.731 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -70.56 -32.3 69.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.377 1.071 . . . . 0.0 112.693 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.85 -39.51 89.4 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.727 0.811 . . . . 0.0 110.995 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -55.17 -45.97 75.75 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.359 0.981 . . . . 0.0 111.69 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.33 -43.07 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 110.816 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -64.36 -46.0 85.31 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.562 0.745 . . . . 0.0 112.792 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.3 mt -65.57 -54.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.959 1.303 . . . . 0.0 110.688 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.04 -34.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.269 -0.894 . . . . 0.0 111.153 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -24.58 52.5 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-N 119.233 0.924 . . . . 0.0 113.965 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.52 -25.38 8.21 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 125.417 1.484 . . . . 0.0 114.294 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.61 -19.76 20.86 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.197 1.498 . . . . 0.0 114.71 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.99 -34.4 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.552 1.141 . . . . 0.0 112.426 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -85.47 -27.44 25.68 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.326 1.851 . . . . 0.0 113.965 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.995 1.718 . . . . 0.0 113.132 -175.505 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.141 0.496 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.51 114.05 26.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.639 1.575 . . . . 0.0 110.689 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -127.33 -66.08 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.59 1.556 . . . . 0.0 112.455 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -148.77 176.76 10.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.036 1.735 . . . . 0.0 111.17 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -52.02 -29.74 22.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 113.359 175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -55.84 -35.32 66.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.514 1.526 . . . . 0.0 112.744 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -33.11 55.1 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.246 -0.909 . . . . 0.0 111.749 175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.6 -33.22 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.924 0.89 . . . . 0.0 112.108 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -62.31 -29.3 70.34 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.78 -1.2 . . . . 0.0 113.455 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.93 -43.2 88.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.914 0.885 . . . . 0.0 111.182 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.97 -42.11 97.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.537 0.735 . . . . 0.0 112.129 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -54.98 -39.02 68.54 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.21 0.604 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.86 -43.78 86.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.237 1.015 . . . . 0.0 113.073 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -58.12 -43.54 87.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.182 0.993 . . . . 0.0 112.229 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -68.97 -41.64 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.665 0.786 . . . . 0.0 110.801 175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -36.15 65.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.985 1.314 . . . . 0.0 113.2 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.14 -43.67 98.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.51 0.724 . . . . 0.0 111.158 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.26 -45.5 93.07 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.428 -0.795 . . . . 0.0 110.83 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.76 -51.45 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.63 0.772 . . . . 0.0 111.513 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 ptp -62.85 -33.93 76.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.447 1.021 . . . . 0.0 113.478 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -70.5 -54.62 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.179 0.992 . . . . 0.0 110.187 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.96 -34.7 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.506 1.122 . . . . 0.0 111.472 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.0 -24.27 34.29 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.118 0.866 . . . . 0.0 114.0 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.54 -29.19 4.83 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.783 1.659 . . . . 0.0 113.618 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.2 -21.28 29.2 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.651 1.726 . . . . 0.0 114.703 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.73 -34.0 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.662 1.119 . . . . 0.0 112.11 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -26.02 22.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 114.143 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 126.839 2.056 . . . . 0.0 112.585 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -56.81 100.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.773 1.629 . . . . 0.0 112.642 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.93 153.81 50.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.827 2.051 . . . . 0.0 110.876 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.52 139.63 55.64 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.192 0.997 . . . . 0.0 110.192 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -55.64 -30.5 61.08 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 112.92 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -38.2 84.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.768 1.227 . . . . 0.0 112.16 175.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -32.4 65.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.669 1.188 . . . . 0.0 112.482 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.0 mm -61.58 -27.42 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 0.0 111.926 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -58.78 -35.27 72.52 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.016 -1.053 . . . . 0.0 113.167 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -44.07 88.36 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.302 1.041 . . . . 0.0 111.801 175.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -64.39 -41.87 96.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.25 1.02 . . . . 0.0 112.178 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.2 mt -61.22 -40.48 94.15 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.778 0.831 . . . . 0.0 112.111 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -28.17 69.89 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.11 -28.63 63.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.186 -0.946 . . . . 0.0 113.192 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.38 -41.51 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.418 1.087 . . . . 0.0 110.395 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -36.44 79.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.97 1.308 . . . . 0.0 112.116 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.75 -39.78 81.95 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.994 0.918 . . . . 0.0 112.733 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -54.16 -45.26 72.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.387 0.994 . . . . 0.0 111.903 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.77 -42.4 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.483 1.113 . . . . 0.0 110.889 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 mmm -64.99 -46.58 80.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.172 0.989 . . . . 0.0 112.454 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.05 -54.74 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.936 1.294 . . . . 0.0 110.394 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.33 -37.31 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.351 -0.843 . . . . 0.0 110.951 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.12 -22.95 45.05 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 119.095 0.862 . . . . 0.0 114.373 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.98 -23.75 7.6 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.417 1.484 . . . . 0.0 114.381 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.29 -23.18 19.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.348 1.574 . . . . 0.0 114.297 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.97 -32.87 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.647 1.179 . . . . 0.0 112.304 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 -21.13 29.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.76 1.624 . . . . 0.0 114.534 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.469 1.508 . . . . 0.0 112.125 179.077 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 67.9 mttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 91.13 7.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.797 1.181 . . . . 0.0 111.633 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -122.76 168.77 11.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.106 1.362 . . . . 0.0 112.375 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -68.21 162.02 25.87 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.026 0.93 . . . . 0.0 111.412 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -56.37 -29.21 61.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.886 0.874 . . . . 0.0 113.261 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -62.6 -28.03 69.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.816 1.647 . . . . 0.0 113.087 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -84.68 -39.92 18.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.757 1.223 . . . . 0.0 111.096 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.28 -48.4 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.198 0.999 . . . . 0.0 110.799 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -58.89 -31.85 68.97 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -60.52 -44.57 95.88 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.58 1.082 . . . . 0.0 112.059 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -72.14 -42.29 66.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.618 0.767 . . . . 0.0 111.575 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.65 -29.37 70.02 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.593 0.757 . . . . 0.0 112.423 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -33.18 68.47 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.404 1.081 . . . . 0.0 113.389 175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -67.32 -25.89 66.24 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.329 -0.857 . . . . 0.0 113.218 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mm -59.89 -40.87 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.094 -1.004 . . . . 0.0 110.516 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -70.98 -32.06 68.8 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.335 1.054 . . . . 0.0 112.84 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.17 -44.54 92.14 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.953 0.797 . . . . 0.0 111.236 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -55.25 -43.99 75.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.93 0.492 . . . . 0.0 111.875 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.06 -43.82 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.78 0.832 . . . . 0.0 111.191 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.1 mtm -66.68 -42.1 87.04 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.297 0.953 . . . . 0.0 113.162 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.52 -54.53 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.0 -30.9 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.22 -0.925 . . . . 0.0 111.482 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.79 -25.09 43.32 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.315 0.962 . . . . 0.0 114.141 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.16 -25.77 5.72 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.562 1.553 . . . . 0.0 114.037 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.58 -18.72 29.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.204 1.502 . . . . 0.0 114.728 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.6 -33.53 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 119.943 1.247 . . . . 0.0 112.074 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -18.87 30.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.161 1.385 . . . . 0.0 114.388 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.987 2.115 . . . . 0.0 111.799 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.4 tttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.82 124.96 23.35 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.024 0.929 . . . . 0.0 111.291 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.16 170.2 14.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.641 1.177 . . . . 0.0 112.16 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.01 152.25 35.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.91 1.684 . . . . 0.0 111.959 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -53.49 -26.64 21.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.629 1.571 . . . . 0.0 114.128 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -24.15 59.44 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.929 1.691 . . . . 0.0 113.468 175.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -82.59 -42.71 17.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.772 1.229 . . . . 0.0 111.448 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.1 mm -62.41 -46.33 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.916 1.286 . . . . 0.0 110.855 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -61.49 -29.49 70.01 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -44.6 94.54 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.188 0.995 . . . . 0.0 111.664 175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -70.95 -42.75 69.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.141 0.976 . . . . 0.0 111.93 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.77 -29.07 69.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -32.7 71.01 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.217 -0.927 . . . . 0.0 112.853 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -66.76 -27.01 67.26 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.45 -38.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.009 -1.057 . . . . 0.0 111.034 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.25 -28.86 61.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.609 -0.682 . . . . 0.0 112.665 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.99 -39.68 95.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.99 0.916 . . . . 0.0 111.654 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.1 -45.4 71.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.496 0.718 . . . . 0.0 111.609 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.97 -43.65 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.092 0.957 . . . . 0.0 110.934 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.1 mtm -66.7 -39.49 88.08 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.934 0.788 . . . . 0.0 113.064 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.0 mt -66.94 -54.67 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.526 1.13 . . . . 0.0 110.918 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.08 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.238 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.67 42.29 Favored Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.806 0.73 . . . . 0.0 114.252 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.9 -23.98 7.52 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.501 1.524 . . . . 0.0 114.285 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.46 -22.27 20.51 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.189 1.494 . . . . 0.0 114.644 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.5 -30.52 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.551 1.14 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.14 -13.74 35.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.544 1.938 . . . . 0.0 114.623 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.814 2.045 . . . . 0.0 112.932 178.528 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -74.35 53.95 0.55 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.097 1.759 . . . . 0.0 113.09 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -71.19 168.24 17.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.944 1.698 . . . . 0.0 111.411 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.64 161.7 14.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.835 0.854 . . . . 0.0 112.628 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -58.34 -33.65 69.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 112.849 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -36.49 83.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.108 0.963 . . . . 0.0 112.083 175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -21.31 63.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.337 1.055 . . . . 0.0 112.848 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.4 mm -59.27 -20.69 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.114 0.966 . . . . 0.0 110.942 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -57.78 -32.49 67.56 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.141 -0.974 . . . . 0.0 111.608 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -36.95 78.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.971 0.908 . . . . 0.0 112.148 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.1 -35.0 64.14 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.548 -0.72 . . . . 0.0 112.412 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.47 -49.72 54.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.587 1.555 . . . . 0.0 112.619 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 24.7 p-90 -77.63 -28.18 51.31 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -64.26 -39.31 93.68 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.106 -0.996 . . . . 0.0 112.342 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.7 mt -60.17 -30.38 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.121 0.968 . . . . 0.0 111.525 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.08 -36.16 78.92 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.792 -1.193 . . . . 0.0 111.665 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.9 mt -58.14 -40.81 82.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.117 0.967 . . . . 0.0 111.783 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -56.3 -44.8 80.21 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.714 0.806 . . . . 0.0 111.608 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.72 -45.4 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.847 0.859 . . . . 0.0 110.737 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.41 -39.77 85.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.43 -54.66 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.461 1.104 . . . . 0.0 110.778 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.53 -36.57 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.968 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.97 -22.04 40.37 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.018 0.827 . . . . 0.0 114.891 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.89 -24.77 6.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.339 1.447 . . . . 0.0 114.553 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.11 -27.32 23.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.081 1.44 . . . . 0.0 113.974 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.19 -33.79 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.622 1.169 . . . . 0.0 112.81 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -81.1 -8.47 59.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.818 1.647 . . . . 0.0 114.289 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.412 2.685 . . . . 0.0 113.141 -176.61 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -65.38 141.74 58.45 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.079 -1.638 . . . . 0.0 111.667 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -70.06 -71.46 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.041 . . . . 0.0 111.008 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -155.41 139.1 16.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.492 1.517 . . . . 0.0 110.213 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.6 p-90 -55.85 -31.44 62.75 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.357 1.063 . . . . 0.0 113.26 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.97 63.87 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.34 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -85.22 -23.59 28.2 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.213 -0.929 . . . . 0.0 112.665 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.9 mm -60.77 -24.98 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.235 1.414 . . . . 0.0 112.171 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -55.45 -32.42 62.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.072 -1.017 . . . . 0.0 113.494 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -60.76 -42.5 97.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.907 0.883 . . . . 0.0 112.247 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -66.82 -43.41 83.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 111.472 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -58.94 -43.56 91.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.782 0.833 . . . . 0.0 111.696 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -33.47 73.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 112.951 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.56 -45.14 89.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.183 0.993 . . . . 0.0 111.457 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 mt -70.62 -35.8 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.939 0.896 . . . . 0.0 111.038 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.92 -41.15 74.15 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.99 -1.069 . . . . 0.0 112.768 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.13 -42.7 86.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.024 0.929 . . . . 0.0 112.224 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.78 -42.43 79.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.894 0.878 . . . . 0.0 112.256 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.99 -45.8 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.903 0.881 . . . . 0.0 110.785 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.7 mtt -63.16 -43.76 97.4 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.09 -54.51 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.444 1.098 . . . . 0.0 110.56 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.14 -34.87 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 O-C-N 121.399 -0.813 . . . . 0.0 111.484 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -25.5 35.37 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 123.906 0.765 . . . . 0.0 114.049 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.63 -31.78 4.74 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.606 1.574 . . . . 0.0 113.647 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 mt -85.27 -18.51 33.73 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.92 -30.9 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.818 1.19 . . . . 0.0 113.061 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.0 -27.86 20.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.718 1.607 . . . . 0.0 114.297 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt . . . . . 0 C--O 1.253 1.275 0 C-N-CA 127.109 2.164 . . . . 0.0 112.951 -176.37 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -63.34 -38.01 89.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.231 1.413 . . . . 0.0 112.194 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -65.61 153.43 41.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.498 1.919 . . . . 0.0 111.401 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -106.29 147.35 29.26 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.488 1.115 . . . . 0.0 111.275 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -55.21 -27.05 43.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.465 1.106 . . . . 0.0 113.073 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.09 -24.91 57.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.657 1.983 . . . . 0.0 112.965 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -104.09 -40.14 6.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.861 1.664 . . . . 0.0 111.254 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.6 mm -59.09 -27.67 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.137 -0.977 . . . . 0.0 112.433 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -55.71 -27.37 50.01 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.822 -1.173 . . . . 0.0 112.42 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -65.23 -29.7 70.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.194 -0.941 . . . . 0.0 112.011 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -79.72 -35.24 39.2 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.359 1.064 . . . . 0.0 111.362 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.09 -48.53 67.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.431 1.492 . . . . 0.0 111.65 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -78.03 -27.69 48.85 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -66.83 -37.79 85.18 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.173 -0.954 . . . . 0.0 112.386 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mt -61.85 -33.79 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.138 -0.976 . . . . 0.0 110.93 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -62.15 -25.11 67.57 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.874 -1.141 . . . . 0.0 112.817 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.7 mt -64.3 -37.54 87.86 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.216 0.916 . . . . 0.0 111.826 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 22' ' ' VAL . 66.2 t80 -55.85 -44.42 78.02 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.499 0.719 . . . . 0.0 111.019 175.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.36 -42.44 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.046 0.939 . . . . 0.0 110.89 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.1 mtt -66.22 -49.2 68.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.612 0.642 . . . . 0.0 112.654 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.92 -54.57 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.18 1.392 . . . . 0.0 110.516 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG21 ' CZ ' ' A' ' 18' ' ' PHE . 63.7 t -66.33 -34.0 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.917 . . . . 0.0 110.858 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.58 -23.31 42.71 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 119.412 1.005 . . . . 0.0 114.724 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.26 -21.08 7.86 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.34 1.448 . . . . 0.0 114.665 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.77 -25.93 19.73 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.876 1.338 . . . . 0.0 113.832 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.14 -29.57 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.724 1.21 . . . . 0.0 112.999 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -84.05 -13.91 51.91 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.724 1.609 . . . . 0.0 114.673 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.3 mttt . . . . . 0 C--O 1.253 1.279 0 C-N-CA 128.968 2.907 . . . . 0.0 114.418 -171.839 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -67.29 96.38 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.276 1.831 . . . . 0.0 112.101 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 163.82 18.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.514 1.126 . . . . 0.0 110.57 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.13 168.85 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.419 1.488 . . . . 0.0 111.215 175.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -58.54 -28.71 65.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.03 0.932 . . . . 0.0 112.674 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -38.74 80.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.621 175.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -66.3 -35.2 79.78 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 112.199 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.4 -53.49 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.067 0.947 . . . . 0.0 111.052 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 t -63.52 -25.42 68.24 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.28 -43.01 92.55 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.64 1.176 . . . . 0.0 111.537 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -69.11 -33.27 73.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.601 -0.687 . . . . 0.0 112.831 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -36.3 80.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.406 0.682 . . . . 0.0 111.717 174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -39.07 78.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.898 0.879 . . . . 0.0 112.784 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -60.12 -41.21 92.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.05 0.94 . . . . 0.0 113.098 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.1 mt -62.16 -53.89 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.361 1.064 . . . . 0.0 110.636 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -57.32 -45.49 84.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.756 1.223 . . . . 0.0 112.478 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.09 -48.23 79.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.428 1.491 . . . . 0.0 111.876 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -56.14 -48.93 75.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.673 0.669 . . . . 0.0 111.58 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.12 -46.35 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.469 0.708 . . . . 0.0 111.039 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.6 mmm -61.13 -42.33 98.34 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.177 0.991 . . . . 0.0 112.771 177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.6 mt -64.24 -54.62 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.785 1.234 . . . . 0.0 110.914 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.21 -32.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.469 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.12 -23.01 30.97 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 118.822 0.737 . . . . 0.0 114.589 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.63 -21.79 6.66 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.737 1.637 . . . . 0.0 114.553 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.31 -17.94 24.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.187 1.493 . . . . 0.0 114.544 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.59 -32.66 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 120.728 -1.232 . . . . 0.0 112.139 177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -28.2 26.6 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.528 1.531 . . . . 0.0 114.669 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.563 1.545 . . . . 0.0 113.658 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 tttm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -113.84 117.66 32.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.96 1.704 . . . . 0.0 110.878 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -66.83 169.88 7.4 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.239 1.815 . . . . 0.0 111.435 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -122.52 156.88 33.24 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.714 1.206 . . . . 0.0 111.813 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 22.5 p-90 -59.63 -28.58 67.33 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.247 1.019 . . . . 0.0 113.178 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -30.89 71.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.171 0.989 . . . . 0.0 112.936 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.92 -27.57 63.88 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.938 -1.101 . . . . 0.0 111.603 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.2 mm -65.49 -37.03 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.963 1.305 . . . . 0.0 111.581 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 p -61.06 -34.32 74.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.262 0.937 . . . . 0.0 112.224 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.77 -47.5 84.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.353 1.461 . . . . 0.0 111.556 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -71.02 -41.4 70.92 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.689 1.196 . . . . 0.0 112.963 175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 66.3 mt -60.11 -34.85 74.05 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.073 0.949 . . . . 0.0 112.66 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -43.11 97.39 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.691 -0.631 . . . . 0.0 112.19 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -57.38 -28.25 63.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.293 1.037 . . . . 0.0 113.322 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.66 -43.9 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.305 1.042 . . . . 0.0 111.593 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -74.1 -34.67 64.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.255 . . . . 0.0 112.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.83 -38.41 78.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.783 0.833 . . . . 0.0 111.831 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.901 0.773 . . . . 0.0 111.552 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.18 -42.13 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.135 0.974 . . . . 0.0 111.244 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.8 mmt -62.38 -46.84 86.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.702 0.801 . . . . 0.0 111.9 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.94 -54.54 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.586 1.155 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.93 -32.6 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.411 -0.806 . . . . 0.0 111.471 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.82 -26.75 41.49 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 119.346 0.976 . . . . 0.0 113.98 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.96 -32.93 4.21 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.516 1.532 . . . . 0.0 113.173 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.82 -18.67 43.15 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.644 1.722 . . . . 0.0 114.958 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.41 -33.8 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.743 1.156 . . . . 0.0 112.835 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -88.54 -33.75 17.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.047 1.739 . . . . 0.0 113.622 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.17 1.788 . . . . 0.0 113.211 178.599 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 119.818 -0.134 . . . . 0.0 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -67.72 131.95 46.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.847 0.859 . . . . 0.0 111.79 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -126.71 -78.32 0.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.16 1.784 . . . . 0.0 111.008 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.15 171.58 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.526 1.93 . . . . 0.0 110.306 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -51.56 -21.69 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.056 1.742 . . . . 0.0 114.774 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.9 -21.15 63.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.76 1.224 . . . . 0.0 112.34 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -23.06 67.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.498 -1.376 . . . . 0.0 112.87 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -68.29 -43.22 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.756 1.222 . . . . 0.0 110.946 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -70.34 -23.21 62.78 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.136 -0.978 . . . . 0.0 112.961 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -59.63 -38.47 81.44 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.956 0.902 . . . . 0.0 111.726 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -66.51 -46.84 74.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.25 1.02 . . . . 0.0 111.801 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 15' ' ' ILE . 1.8 mt -54.55 -41.53 69.89 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.794 1.237 . . . . 0.0 112.224 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.15 -43.73 82.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.289 0.636 . . . . 0.0 111.874 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -66.18 -40.54 90.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.708 0.803 . . . . 0.0 112.295 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 12' ' ' LEU . 41.8 mt -57.51 -52.35 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.117 0.967 . . . . 0.0 110.785 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -68.41 -37.18 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -58.35 -39.69 80.17 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.631 1.172 . . . . 0.0 112.006 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -55.89 -43.9 77.66 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.704 0.684 . . . . 0.0 112.209 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.55 -42.54 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.057 0.943 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 41.5 mmm -62.97 -46.38 87.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.889 0.876 . . . . 0.0 112.583 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.05 -54.66 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.892 0.877 . . . . 0.0 110.876 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.1 t -64.19 -33.31 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.491 -0.756 . . . . 0.0 111.082 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.28 -23.88 42.67 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-N 119.062 0.846 . . . . 0.0 114.421 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.29 -21.38 7.34 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.566 1.555 . . . . 0.0 114.533 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.2 mt -88.45 -26.44 22.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.289 1.545 . . . . 0.0 114.327 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.42 -30.0 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.562 1.145 . . . . 0.0 112.936 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.78 -15.04 43.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.941 1.696 . . . . 0.0 114.635 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.209 0 C-N-CA 125.963 1.705 . . . . 0.0 113.125 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -73.28 117.45 15.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.339 1.856 . . . . 0.0 113.068 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.81 141.46 40.83 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.947 2.099 . . . . 0.0 109.702 175.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -76.72 148.21 36.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 111.159 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -61.83 -27.97 69.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.31 -0.869 . . . . 0.0 112.685 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.07 -30.29 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.13 0.972 . . . . 0.0 112.961 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.28 -22.12 66.29 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.052 -1.03 . . . . 0.0 112.492 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.88 -28.09 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.036 -1.04 . . . . 0.0 111.674 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -63.67 -33.54 75.85 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.003 -1.061 . . . . 0.0 112.765 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.45 -41.78 79.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.627 1.171 . . . . 0.0 111.377 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -61.73 -40.6 95.66 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.121 0.968 . . . . 0.0 113.106 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -46.41 80.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.153 0.581 . . . . 0.0 111.557 175.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -34.53 74.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.267 1.027 . . . . 0.0 113.433 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.96 -41.34 91.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.451 1.101 . . . . 0.0 112.5 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.2 -44.67 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.518 1.127 . . . . 0.0 110.434 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -57.06 -41.76 79.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.676 0.79 . . . . 0.0 111.831 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.32 -47.33 85.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.485 1.114 . . . . 0.0 112.079 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.56 -44.68 77.03 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.092 0.86 . . . . 0.0 112.31 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.1 mt -58.68 -43.04 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.147 175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -47.86 75.19 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.91 0.777 . . . . 0.0 112.314 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.28 -54.66 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 110.242 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.34 -34.27 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.448 -0.783 . . . . 0.0 111.201 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.69 -23.96 46.13 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 119.347 0.976 . . . . 0.0 114.438 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.96 -25.47 6.15 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.44 1.495 . . . . 0.0 114.179 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.78 -18.66 27.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.149 1.475 . . . . 0.0 114.511 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.98 -34.08 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 119.962 1.256 . . . . 0.0 112.671 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -28.14 32.88 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.7 1.6 . . . . 0.0 114.086 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 130.857 3.663 . . . . 0.0 115.655 -174.908 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -136.96 119.79 16.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.51 1.924 . . . . 0.0 110.941 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -120.68 -66.4 1.06 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.045 1.738 . . . . 0.0 111.336 175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -139.26 155.31 47.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.704 1.602 . . . . 0.0 111.324 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 p-90 -58.21 -28.3 64.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.646 1.178 . . . . 0.0 113.255 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -55.46 -44.31 76.31 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.14 1.376 . . . . 0.0 112.231 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -67.43 -39.68 85.47 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.495 -0.753 . . . . 0.0 111.694 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.27 -51.46 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.393 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 t -66.66 -29.52 69.56 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.346 -0.846 . . . . 0.0 113.157 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.69 -43.61 90.06 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -68.8 -33.16 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.54 -35.25 75.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.482 1.113 . . . . 0.0 112.034 176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -29.88 71.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.213 1.005 . . . . 0.0 113.708 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.34 -41.71 85.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.249 1.02 . . . . 0.0 112.076 175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.36 -41.56 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.061 0.944 . . . . 0.0 110.742 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -63.67 -38.2 90.21 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.94 0.896 . . . . 0.0 113.306 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.92 -38.15 81.52 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.853 0.751 . . . . 0.0 112.618 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -56.06 -41.64 75.4 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.098 0.863 . . . . 0.0 112.334 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.1 mt -61.07 -39.91 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.181 0.992 . . . . 0.0 111.321 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.0 mmm -68.43 -45.99 71.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.212 1.005 . . . . 0.0 111.761 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.34 -54.64 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.739 1.215 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.28 -32.38 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 121.393 -0.817 . . . . 0.0 111.279 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.6 -24.28 46.67 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 119.485 1.038 . . . . 0.0 114.594 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.24 -25.57 6.04 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.373 1.463 . . . . 0.0 114.222 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -87.65 -18.95 28.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.851 1.325 . . . . 0.0 114.23 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.51 -37.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.628 1.104 . . . . 0.0 112.09 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -30.09 31.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.973 1.309 . . . . 0.0 113.768 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 mttm . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 130.03 3.332 . . . . 0.0 115.599 -168.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 119.504 -0.284 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -126.33 89.75 3.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.174 1.39 . . . . 0.0 111.249 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -65.16 -62.09 1.75 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.65 1.18 . . . . 0.0 112.422 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -153.15 160.38 42.85 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 110.984 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.88 -35.19 77.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.687 0.795 . . . . 0.0 112.882 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -61.91 -31.23 71.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.386 1.074 . . . . 0.0 112.699 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -59.89 -27.62 66.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.552 1.141 . . . . 0.0 111.954 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.8 mm -72.05 -45.97 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.27 1.028 . . . . 0.0 110.565 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.8 p -63.48 -21.38 66.28 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -58.17 -37.23 74.32 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.987 1.315 . . . . 0.0 111.235 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -75.02 -38.05 61.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 113.216 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.05 -41.45 71.44 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.368 0.985 . . . . 0.0 112.252 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -37.91 76.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 112.44 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.03 -41.47 96.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.723 1.209 . . . . 0.0 112.948 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mt -68.14 -45.83 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.683 0.793 . . . . 0.0 110.694 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -56.32 -39.57 72.98 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.448 1.099 . . . . 0.0 113.224 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.37 -43.22 96.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.601 0.76 . . . . 0.0 111.527 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -56.43 -41.51 76.54 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.153 0.888 . . . . 0.0 112.595 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.21 -44.49 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.885 0.874 . . . . 0.0 110.794 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 mmm -67.91 -43.65 78.74 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.699 0.8 . . . . 0.0 112.797 176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.8 mt -61.66 -54.62 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.324 1.05 . . . . 0.0 110.342 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.13 -34.59 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.153 -0.967 . . . . 0.0 111.218 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -23.9 45.48 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-N 119.419 1.009 . . . . 0.0 114.334 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.0 -24.06 6.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.417 1.484 . . . . 0.0 114.321 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -89.92 -20.21 23.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.396 1.598 . . . . 0.0 114.48 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.95 -29.47 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.662 1.119 . . . . 0.0 112.514 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -18.91 23.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.884 1.674 . . . . 0.0 114.543 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 126.349 1.859 . . . . 0.0 112.77 177.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 ptmm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -135.98 150.75 49.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.851 1.66 . . . . 0.0 111.32 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -66.14 1.02 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.685 1.594 . . . . 0.0 111.127 -176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.12 164.43 34.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.488 1.115 . . . . 0.0 111.635 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -60.72 -30.26 69.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.765 0.826 . . . . 0.0 112.919 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.35 -29.2 69.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.802 1.241 . . . . 0.0 113.141 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -65.19 -42.09 93.91 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.861 -1.15 . . . . 0.0 110.316 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.4 mm -63.17 -45.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.998 1.319 . . . . 0.0 111.832 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -63.07 -28.36 70.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.99 -42.01 94.9 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.081 0.855 . . . . 0.0 110.998 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -67.68 -35.07 78.16 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.631 0.772 . . . . 0.0 112.131 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.11 -29.59 68.7 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.764 . . . . 0.0 112.201 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -30.77 70.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.895 0.878 . . . . 0.0 113.077 175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -63.47 -34.03 76.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.136 0.974 . . . . 0.0 112.244 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.8 mm -64.38 -43.49 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 121.571 -0.706 . . . . 0.0 110.002 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -64.8 -37.55 87.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.925 0.89 . . . . 0.0 112.886 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.37 -46.45 76.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.154 0.888 . . . . 0.0 111.541 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -55.44 -43.11 75.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.411 0.685 . . . . 0.0 112.354 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.99 -44.04 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.987 0.915 . . . . 0.0 111.167 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.1 mtt -62.99 -49.94 72.71 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.171 0.896 . . . . 0.0 112.03 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.56 -54.29 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.778 1.231 . . . . 0.0 110.511 -175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.55 -34.09 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.333 -0.854 . . . . 0.0 111.276 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.64 -24.1 46.34 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 119.464 1.029 . . . . 0.0 114.282 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.75 -27.43 6.02 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.482 1.515 . . . . 0.0 114.231 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.85 -18.71 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.071 1.435 . . . . 0.0 114.576 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.73 -33.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.389 0.995 . . . . 0.0 112.33 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.46 -28.47 25.01 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.672 1.189 . . . . 0.0 114.096 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.4 mttp . . . . . 0 N--CA 1.484 1.255 0 C-N-CA 130.604 3.562 . . . . 0.0 117.605 -177.54 . . . . . . . . 0 0 . 1 stop_ save_